Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013

M Murti; M Krajden; M Petric; J Hiebert; F Hemming; B Hefford; M Bigham; P Van Buynder

doi:10.2807/1560-7917.ES2013.18.49.20649

Rapid communications Open Access

Like 0

Download

Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013
M Murti¹ , M Krajden² , M Petric² , J Hiebert³ , F Hemming¹ , B Hefford⁴ , M Bigham¹ , P Van Buynder¹
View Affiliations Hide Affiliations

Affiliations: ¹ Fraser Health Authority, Surrey, British Columbia, Canada ² Public Health Microbiology and Reference Laboratory British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada ³ National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada ⁴ 1-1400 George St., White Rock, British Columbia, Canada

Correspondence:
M Murti
michelle.murti fraserhealth.ca
View Citation Hide Citation

Citation style for this article: Murti M, Krajden M, Petric M, Hiebert J, Hemming F, Hefford B, Bigham M, Van Buynder P. Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013. Euro Surveill. 2013;18(49):pii=20649. https://doi.org/10.2807/1560-7917.ES2013.18.49.20649 Received: 15 Nov 2013

Abstract

We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster.